Published by Term Insurance Brokers — an independent brokerage licensed in 35+ states, representing 30+ top-rated carriers. Updated August 2026.
Quick Answer: Yes, you can get life insurance after skin cancer — often at preferred or standard rates. Basal cell and squamous cell carcinoma (the most common types) are typically viewed as near non-events by underwriters when fully treated with clear margins and consistent dermatology follow-up. Stage I melanoma is also widely insurable after a 1–2 year disease-free period. Advanced melanoma (Stage II+) requires longer waits and table-rated coverage. These are general industry patterns — actual outcomes vary by carrier, so working with a broker who can shop your specific case matters.
How Do Underwriters View Skin Cancer?
Skin cancer is the most commonly diagnosed cancer in the U.S. — more than 5 million cases are treated every year. Because the underwriting world sees these cases constantly, the framework is clear and consistent: the type of skin cancer, the treatment, the margins, and the follow-up care determine the rate outcome. Skin cancer is generally underwritten very differently from other cancer histories.
What Are the Most Common Types of Skin Cancer (and How Are They Underwritten)?
Basal Cell Carcinoma (BCC)
The most common and most forgiving type. If your lesion was fully removed, margins were clear, and you keep up with annual dermatology visits, most carriers treat it as a near non-event. Preferred rates are often available — sometimes even Preferred Plus, though this varies by carrier.
Squamous Cell Carcinoma (SCC)
Slightly more aggressive than BCC, but early-stage SCC that has been fully treated typically qualifies for standard or preferred rates. Underwriters look more carefully at location, depth, and recurrence history.
Melanoma
Melanoma is underwritten more strictly because of its higher recurrence and metastasis risk. General outcomes by stage — actual required waiting periods vary meaningfully by carrier, and some companies are notably more conservative than others:
- Stage 0 / Melanoma in situ: Some carriers offer standard rates as early as 1 year disease-free; others prefer 2–3 years, with preferred rates possible after that.
- Stage I (thin melanoma, Breslow under 1.0mm): Many carriers will consider standard rates after 1–2 years, though this is not universal.
- Stage II (Breslow over 1.0mm): Coverage available but typically table-rated; a 2–5 year disease-free period is common before better rates are considered.
- Stage III (lymph node involvement): Limited carriers; longer disease-free periods (often 5+ years) and significant table ratings are common.
- Stage IV (metastatic): Traditional underwriting is rarely available; guaranteed issue whole life is usually the path.
How Long After Treatment Should You Wait To Apply?
The table below reflects general industry patterns. Treat these as a starting point for a conversation with your broker, not a fixed rule — the same case can be viewed very differently from one carrier to the next.
| Type | Typical Wait Time | Best-Case Rate Class |
|---|---|---|
| Basal cell carcinoma | None to minimal — often insurable soon after treatment | Preferred Plus / Preferred |
| Squamous cell carcinoma | 0–12 months post-treatment | Standard / Preferred |
| Melanoma in situ | 1 year disease-free (some carriers prefer longer) | Standard, Preferred after 2–3 years |
| Stage I melanoma | 1–2 years disease-free | Standard |
| Stage II melanoma | 2–5 years disease-free | Table-rated |
| Stage III+ melanoma | 5+ years disease-free | Specialty / high-risk carrier |
What Helps Your Skin Cancer Life Insurance Application?
- Complete pathology report with type, depth (Breslow for melanoma), and margin status.
- Dermatologist’s note confirming clear margins and consistent follow-up.
- Annual skin-check documentation. Underwriters favor seeing a consistent surveillance pattern.
- No recurrence history — or clear documentation of how any recurrence was managed.
- Independent broker who knows the carrier landscape for skin cancer cases (especially melanoma), since outcomes for the same case can differ significantly between companies.
Key Takeaways
- Basal cell and squamous cell carcinoma are usually treated favorably when fully resected with clear margins.
- Stage 0 and Stage I melanoma are often insurable at standard rates after roughly 1–2 disease-free years, though this varies by carrier.
- Stage II+ melanoma typically requires longer waits and often results in table-rated coverage.
- Stage IV melanoma typically requires guaranteed issue whole life rather than traditional underwriting.
- Consistent annual dermatology follow-up is one of the strongest positive signals for any skin cancer underwriting case, and carrier selection matters enormously given how much outcomes vary.
Get a Free Quote
Skin cancer cases are routine at Term Insurance Brokers. We’re licensed independent insurance agents representing 30+ top-rated carriers and know which take the most favorable view of each skin cancer type and stage. Call 888-972-0024 or request a free quote online.
Get Your Free Quote Today
No cost. No obligation. We shop 30+ carriers to find the right fit for you.
| Call 888-972-0024 | Get a Quote |
Authoritative Resources
- American Cancer Society — Basal & Squamous Cell Skin Cancer
- American Cancer Society — Melanoma Skin Cancer
- NAIC — Life Insurance Consumer Information